Ana Burgeiro

Ana Burgeiro

Auto-generated profile, based on publicly available information

Ana Burgeiro

Center for Neuroscience and Cell Biology, Center for Inovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2013 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
FCFilipa Carvalho
Filipa Carvalho
ABAna Burgeiro
Ana Burgeiro
RGRita Garcia
Rita Garcia
AMAntónio J. Moreno
António J. Moreno
RCRui A. Carvalho
Rui A. Carvalho
POPaulo Oliveira
Paulo Oliveira

1 June 2011 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
CDCatia V. Diogo
Catia V. Diogo
NMNuno G. Machado
Nuno G. Machado
IBInes A. Barbosa
Ines A. Barbosa
TSTeresa L. Serafim
Teresa L. Serafim
ABAna Burgeiro
Ana Burgeiro
POPaulo Oliveira
Paulo Oliveira
Metabolic regulation is largely dependent on mitochondria, which play an important role in energy homeostasis. Mitochondrial dysfunction results in an imbalanced energy supply to the cell, which may compromise its survival. Due to the role of mitochondrial factors/events in several apoptotic pathways, the possibility of targeting that organelle in the tumor cell, leading to its elimination is very attractive, although the safety issue is problematic. Berberine, a benzyl-tetra isoquinoline alkaloid extracted from plants of the Berberidaceae family, has been extensively used for many centuries, especially in the traditional Chinese and Native American medicine. Several evidences suggest that berberine possesses several therapeutic uses, including anti-tumoral activity. The present review supplies evidence that berberine is a safe anti-cancer agent, exerting several effects on mitochondria, including inhibition of mitochondrial Complex I and interaction with the adenine nucleotide translocator which can explain several of the described effects on tumor cells.

1 July 2011 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
ABAna Burgeiro
Ana Burgeiro
CGConsuelo Gajate
Consuelo Gajate
EDEl Habib Dakir
El Habib Dakir
JVJanny A Villa-Pulgarin
Janny A Villa-Pulgarin
POPaulo Oliveira
Paulo Oliveira
FMFaustino Mollinedo
Faustino Mollinedo
The natural isoquinoline alkaloid berberine exhibits a wide spectrum of biological activities including antitumor activity, but its mechanism of action remains to be fully elucidated. Here, we report that berberine induced apoptosis in human melanoma cells, through a process that involved mitochondria and caspase activation. Berberine-induced activation of a number of caspases, including caspases 3, 4, 7, 8, and 9. Pan-caspase inhibitor, z-VAD-fmk, and caspase-8 and caspase-9 inhibitors prevented apoptosis. Berberine also led to the generation of the p20 cleavage fragment of BAP31, involved in directing proapoptotic signals between the endoplasmic reticulum and the mitochondria. Treatment of SK-MEL-2 melanoma cells with berberine induced disruption of the mitochondrial transmembrane potential, release of cytochrome c and apoptosis-inducing factor from the mitochondria to the cytosol, generation of reactive oxygen species (ROS), and a decreased ATP/ADP ratio. Overexpression of bcl-xL by gene transfer prevented berberine-induced cell death, mitochondrial transmembrane potential loss, and cytochrome c and apoptosis-inducing factor release, but not ROS generation. N-acetyl-L-cysteine inhibited the production of ROS, but did not abrogate the berberine-induced apoptosis. Inhibition of extracellular signal-regulated kinase (ERK) phosphorylation, by using the mitogen-activated protein kinase/ERK kinase inhibitor PD98059, and reduction of B-RAF levels by silencing RNA induced cell death of SK-MEL-2 cells, and diminished the berberine concentration required to promote apoptosis. These data show that berberine-induced apoptosis in melanoma cells involves mitochondria and caspase activation, but ROS generation was not essential. Our results indicate that inhibition of B-RAF/ERK survival signaling facilitates the cell death response triggered by berberine.

1 April 2013 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ABAna Burgeiro
Ana Burgeiro
ABAna C. Bento
Ana C. Bento
CGConsuelo Gajate
Consuelo Gajate
POPaulo Oliveira
Paulo Oliveira
FMFaustino Mollinedo
Faustino Mollinedo

1 August 2009 in Toxicology in Vitro
Verified
Journal Article
Closed access
CDCátia V. Diogo
Cátia V. Diogo
Luís Manuel Lourenço FélixLuís Manuel Lourenço Félix
Luís Manuel Lourenço Félix
SVSérgio Vilela
Sérgio Vilela
ABAna Burgeiro
Ana Burgeiro
IBInês A. Barbosa
Inês A. Barbosa
Francisco PeixotoFrancisco Peixoto
Francisco Peixoto

31 December 2010 in Neurobiology of Disease
Verified
Journal Article
Closed access
MVM. Vieira
M. Vieira
JFJ. Fernandes
J. Fernandes
ABA. Burgeiro
A. Burgeiro
GTG.M. Thomas
G.M. Thomas
RHR.L. Huganir
R.L. Huganir
ASArmanda Emanuela Santos
Armanda Emanuela Santos